We are pioneering CRISPR-based microbial gene therapy

Our Impact

Precision killing of bacteria has the potential to revolutionize the management of untreatable and difficult-to-treat conditions as well as complex diseases directly impacted by the human microbiota. 

More than $90M Raised

SNIPR Biome raised $50M in 2019 in one of the largest Series A’s in Europe from four large European funds to advance CRISPR-based microbiome drugs to human clinical trials. In 2025, more than $40M was raised in a Series B round.

30+ Scientists

Since its inception in August 2017, SNIPR Biome has over the years grown to a team of more than 30 - predominantly PhDs.

Several Patent Families

The SNIPR Biome scientists have made several innovative and novel discoveries which are being protected in several separate patent families – +30 of which have already granted as US patents.

Work With Us

SNIPR Biome is the leading CRISPR Microbiome company. As a growing company we are always looking for new talents to join our team in the capital of Denmark, Copenhagen. Our main goal is to engineer microbiomes using CRISPR technology, to treat a number of serious and life-threatening diseases, ranging from IBD, Multi-drug resistant infections to cancer. The working environment is fun, fast-paced, collaborative and outcome focused. If you are curious, smart and passionate about inventing tomorrow’s medicine then drop us a line.